Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation

Update Il y a 4 ans
Reference: NCT00408473

Woman and Man

Extract

The purpose of the study is to assess the efficacy of flecainide controlled release (CR) in the prevention of recurrent AF during 9 months of active treatment compared to placebo in patients with only one documented AF episode.


Inclusion criteria

  • Atrial fibrillation


Links